- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on African American Men in France
Total 55 results
-
Drugs for Neglected DiseasesSanofiCompletedHuman African TrypanosomiasisFrance
-
Drugs for Neglected DiseasesCompletedTrypanosomiasis, AfricanFrance
-
Drugs for Neglected DiseasesTerminated
-
Drugs for Neglected DiseasesCompletedHuman African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158Parasitic Diseases | Protozoan Infections | Trypanosomiasis | Trypanosomiasis, AfricanFrance
-
University Hospital, Clermont-FerrandService de Biologie de la Reproduction : AMP-CECOS; EA 975, Laboratoire de BDR and other collaboratorsCompletedHealthy Volunteers | Normocholesterolaemic Men | Normozoospermic MenFrance
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedPeople Living With HIV | Men Who Have Sex With MenFrance
-
H. Lundbeck A/SCompleted
-
University Hospital, ToulouseCompleted
-
University of the French West Indies and French...CompletedHealthy and Physically Active Young MenFrance
-
Institut National de Recherche pour l'Agriculture...RecruitingNon Dependant 60 to 75 Year-old Men and WomenFrance
-
University Hospital, Clermont-FerrandRecruitingHealthy | Overweight | MenFrance
-
University Hospital, Clermont-FerrandUnknownMen in Relation | Couple Whose Taken Care in Medical Assisted to ReproductionFrance
-
University of Rennes 2RecruitingHealthy Young Women | Healthy Young MenFrance
-
University Hospital, BordeauxRecruitingMen Who Have Sex With MenFrance
-
Laboratoire des Adaptations Métaboliques à l'Exercice...Completed
-
University Hospital, CaenRecruitingMean Arterial PressureFrance
-
Joan BottorffUniversity of British Columbia; University of Alberta; Newcastle University; Athabasca... and other collaboratorsCompletedMental Health Wellness 1 | Health Behavior | Health Knowledge, Attitudes, Practice | MenCanada
-
Central Hospital, Nancy, FranceHospices Civils de Lyon; Centre Hospitalier Régional Metz-ThionvilleCompleted
-
BayerCompletedProstate Cancer | Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea | Hypersexuality in Men | Sexual Deviations in MenSpain, Germany, Netherlands, Poland, France
-
Assistance Publique - Hôpitaux de ParisAgence de La BiomédecineCompleted
-
Poitiers University HospitalTerminatedMen Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.France
-
Clinique de la SauvegardeGCS Ramsay Santé pour l'Enseignement et la RechercheCompletedCardiopulmonary Bypass | Cerebral Autoregulation | Mean Arterial PressureFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompletedMEK Inhibitor-Associated Serous RetinopathyFrance
-
Groupe Hospitalier du HavreNot yet recruitingPhysical Activity | Rehabilitation | COPD | TENFrance
-
Assistance Publique - Hôpitaux de ParisCompletedDrepanocytic Men Treated by Hydroxyurea for the First TimeFrance
-
Centre Hospitalier Universitaire DijonNot yet recruitingNeuroendocrine Tumors | MEN1 MutationFrance
-
University Hospital, Clermont-FerrandGroupama foundation; Biochemistry Lab University Hospital Clermont-FerrandRecruitingWomen and Men Over 18 Years Old | AF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AF | Able to Give His Non Opposition to Participate to the StudyFrance
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Liver | Metastatic Breast Carcinoma | Metastatic Malignant Neoplasm in the Lung and other conditionsUnited States, Canada, Saudi Arabia, Korea, Republic of
-
Assistance Publique - Hôpitaux de ParisUnknownEssential Thrombocythemia | MPNFrance
-
Centre Hospitalier Universitaire DijonRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueNovartisCompletedNon Small Cell Lung Cancer | MET Alterations | METex14 MutationsFrance
-
argenxRecruitingMultifocal Motor Neuropathy (MMN)United Kingdom, Spain, United States, Italy, Netherlands, Germany, France, Belgium, Canada, Poland, Austria
-
Incyte CorporationActive, not recruitingMPN (Myeloproliferative Neoplasms)United States, France, United Kingdom, Spain, Canada, Japan, Germany, Switzerland, Belgium, Austria, Italy
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
University of California, IrvineRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasm | MPNUnited States
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
-
Boehringer IngelheimCompletedArthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)Austria, Canada, Czechia, Finland, Netherlands, Sweden
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia
-
Novartis PharmaceuticalsCompletedMacular Edema (ME)Russian Federation, Turkey, United Kingdom, Belgium, Australia, Hungary, Switzerland, Germany, Italy, Korea, Republic of, Israel, Spain, France, Latvia, Netherlands, Slovakia, Czech Republic, Singapore, Canada
-
Incyte CorporationCompletedProspective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)MPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2France, Germany, Australia, United States, United Kingdom, Canada
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States